Naples Global Advisors LLC Has $7.32 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Naples Global Advisors LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,468 shares of the healthcare conglomerate’s stock after buying an additional 428 shares during the period. Naples Global Advisors LLC’s holdings in UnitedHealth Group were worth $7,319,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. International Assets Investment Management LLC lifted its stake in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares in the last quarter. Accredited Investors Inc. boosted its holdings in UnitedHealth Group by 9,235.4% during the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after purchasing an additional 776,516 shares during the last quarter. Raymond James & Associates lifted its position in shares of UnitedHealth Group by 33.1% during the 3rd quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock worth $1,380,661,000 after buying an additional 587,088 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec grew its holdings in shares of UnitedHealth Group by 129.7% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after acquiring an additional 581,324 shares in the last quarter. Finally, State Street Corp lifted its holdings in UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after acquiring an additional 563,554 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently commented on UNH. KeyCorp reiterated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Barclays decreased their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Down 1.2 %

Shares of NYSE UNH opened at $527.31 on Thursday. The business has a 50-day moving average of $526.25 and a 200-day moving average of $563.96. The firm has a market capitalization of $485.27 billion, a price-to-earnings ratio of 34.02, a PEG ratio of 1.45 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the company posted $5.83 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.